News summary

Digbi Health combines hormone therapy, GLP-1 care in single app

Source: Longevity Technology • Published: 05 Oct 2026, 09:41

Summarized by Masters of Longevity from Longevity Technology.

Digbi Health’s expansion describes a telehealth platform merging metabolic and hormonal care into one coordinated app and clinical experience for users.

Digbi Health combines hormone therapy, GLP-1 care in single app
Key Takeaways
  • Digbi Health’s platform now offers GLP-1 prescriptions and hormone replacement therapy through one coordinated clinical team and app.
  • Personalization of care integrates genetics, gut microbiome, continuous glucose data, and advanced blood biomarkers for tailored nutrition and lifestyle plans.
  • Unifying metabolic, inflammatory, and hormonal services on a single platform can reduce per-employee digital health spend for employers and plans.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?